23andMe Lays Off 40% of Staff, Shuts Drug Development Business

HS 11/11/2024
Advertisements




The genetics company is closing a unit that was once seen as core to its future.



Source link

More Stories

Saba Capital finds little appetite for tender offer of shares in Blue Owl, Starwood private credit funds

HS 27/04/2026

Stocks making the biggest moves after hours: LendingClub, Nucor, Rambus, Bed Bath & Beyond and more

HS 27/04/2026

Domino's Pizza stock falls on disappointing sales — and CEO thinks more chains will follow

HS 27/04/2026

You may have missed

Off target: Internet erupts over Vaibhav Sooryavanshi question to Manu Bhaker

HS 27/04/2026

Bank of Japan keeps policy rate steady while raising inflation forecast on Iran war worries

HS 27/04/2026

King Charles: King Charles III to address US Congress amid Iran war tensions: What to expect – The Times of India

HS 27/04/2026

Asia-Pacific markets trade mixed as investors assess latest U.S.-Iran signals

HS 27/04/2026

Sun Pharma buys US-based Organon in $12bn all-cash deal – The Times of India

HS 27/04/2026